FDA Inspection 717438 — Stason Pharmaceuticals, Inc.

Stason Pharmaceuticals, Inc. — FEI 1000160561

The FDA completed an inspection of Stason Pharmaceuticals, Inc. on Mar 18, 2011 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.